What Lies Ahead 2016

AI allows patients, doctors, and payers to make informed decisions based on evidence at a much faster pace.

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

Company aims to provide affordable emergency treatment from overdoses of heroin, fentanyl, and prescription opioids.

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Ojemda is the first systemic therapy approved by the FDA for the treatment of relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or a BRAF V600 mutation.

Healthcare customers and patients are facing more avenues to receive misinformation about drugs than ever before.